Permeation Protection by Waterproofing Mucosal Membranes
| dc.contributor.author | Coderch Negra, Ma. Luisa | |
| dc.contributor.author | Alonso, Cristina | |
| dc.contributor.author | Calpena Campmany, Ana Cristina | |
| dc.contributor.author | Pérez García, M. Lluïsa (Maria Lluïsa) | |
| dc.contributor.author | Clares Naveros, Beatriz | |
| dc.contributor.author | Ramos, Anderson | |
| dc.contributor.author | Martí, Meritxell | |
| dc.date.accessioned | 2024-02-27T12:14:25Z | |
| dc.date.available | 2024-02-27T12:14:25Z | |
| dc.date.issued | 2023-11-29 | |
| dc.date.updated | 2024-02-27T12:14:25Z | |
| dc.description.abstract | <p>The permeability of the oral or nasal mucosa is higher than that of the skin. Mucosa permeability</p><p>depends mainly on the thickness and keratinization degree of the tissues. Their permeability</p><p>barrier is conditioned by the presence of certain lipids. This work has the main aim of reinforcing the</p><p>barrier effect of oral mucosa with a series of formulations to reduce permeation. Transmembrane</p><p>water loss of different formulations was evaluated, and three of them were selected to be tested on</p><p>the sublingual mucosa permeation of drugs. Caffeine, ibuprofen, dexamethasone, and ivermectin</p><p>were applied on porcine skin, mucosa, and modified mucosa in order to compare the effectiveness of</p><p>the formulations. A similar permeation profile was obtained in the different membranes: caffeine</p><p>> ibuprofen~dexamethasone > ivermectin. The most efficient formulation was a liposomal formulation</p><p>composed of lipids that are present in the skin stratum corneum. Impermeability provided</p><p>by this formulation was notable mainly for the low-molecular-weight compounds, decreasing their</p><p>permeability coefficient by between 40 and 80%. The reinforcement of the barrier function of mucosa</p><p>provides a reduction or prevention of the permeation of different actives, which could be extrapolated</p><p>to toxic compounds such as viruses, contaminants, toxins, etc.</p> | |
| dc.format.extent | 1 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 740787 | |
| dc.identifier.issn | 1999-4923 | |
| dc.identifier.uri | https://hdl.handle.net/2445/208111 | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/https://doi.org/10.3390/pharmaceutics15122698 | |
| dc.relation.ispartof | Pharmaceutics, 2023, vol. 15, p. 2698 | |
| dc.relation.uri | https://doi.org/https://doi.org/10.3390/pharmaceutics15122698 | |
| dc.rights | cc-by (c) Coderch, L. et al., 2023 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | |
| dc.subject.classification | Membrana mucosa | |
| dc.subject.classification | Mucosa gastrointestinal | |
| dc.subject.other | Mucous membrane | |
| dc.subject.other | Gastrointestinal mucosa | |
| dc.title | Permeation Protection by Waterproofing Mucosal Membranes | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1